Health care giant Centene agrees to $33.3M settlement in Washington state fraud lawsuit


The state's investigation began in 2019, after a whistleblower reported that one of Centene's subsidiaries was failing to disclose true pharmacy benefits and services costs.

Previous What Pitt BioForge and ElevateBio will mean for the biotech industry — and Hazelwood
Next Fremont migraine patch developer Zosano sold in bankruptcy court for $1M